Mehdi Safdarian

Dr. Mehdi Safdarian

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in Internal and Emergency Medicine
Verified
Journal Article
Open access
PDF file
MPMandana Pouladzadeh
Mandana Pouladzadeh
MSMehdi Safdarian
Mehdi Safdarian
PEPeyman Eshghi
Peyman Eshghi
HAHassan Abolghasemi
Hassan Abolghasemi
ABAlireza Ghorbani Bavani
Alireza Ghorbani Bavani
RHReza Hadaddezfuli
Reza Hadaddezfuli
Evaluating the effect of convalescent plasma (CP) on some cytokine storm indices in severe COVID-19 patients. Totally, 62 patients were randomly assigned into two groups for this clinical trial. Patients in the intervention group received one unit (500 mL) plasma on the admission day plus standard drugs while the controls merely received standard treatments. Eventually, primary and secondary outcomes were evaluated. In the CP group, compared with controls, the mean levels of lymphocytes and IL-10 significantly increased while the levels of IL-6, TNF-α, and IFN-γ decreased (p < 0.05). The length of in-hospital stay, and mortality rate did not significantly reduce in the CP group compared with controls (p > 0.05) while WHO severity scores remarkably improved (p = 0.01), despite the higher frequency of underlying diseases among the CP group (66.7%) vs. controls (33.3%). Although CP has a remarkable immunomodulatory and antiviral potential to improve the cytokine storm and disease severity in COVID-19 patients, it did not considerably affect the mortality rate.


1 June 2012 in Journal of Chromatography A
Verified
Journal Article
Closed access
MSMehdi Safdarian
Mehdi Safdarian
PHPayman Hashemi
Payman Hashemi
MNMalihe Naderlou
Malihe Naderlou


30 March 2023 in Talanta
Verified
Journal Article
Closed access
MBMinoo Barzkar
Minoo Barzkar
AGAlireza Ghiasvand
Alireza Ghiasvand
MSMehdi Safdarian
Mehdi Safdarian